The role of IL-6 and STAT3 in inflammation and cancer

David R. Hodge(National Cancer Institute), Elaine M. Hurt(Science Applications International Corporation (United States)), William L. Farrar(Center for Cancer Research)

European Journal of Cancer

October 3, 2005

10.1016/j.ejca.2005.08.016

Cited by 968

Abstract

Related Papers

Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway

Peter C. Heinrich, Iris Behrmann, Gerhard Müller‐Newen et al.|Biochemical Journal|1998|2.1k

Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines.

Ming Zhu Fang, Yimin Wang, Ni Ai et al.|PubMed|2003|1.1k

JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis

Linda S. Steelman, Steven C. Pohnert, J G Shelton et al.|Leukemia|2004|686

IL-6 signal transduction and its physiological roles: the signal orchestration model

Daisuke Kamimura, Katsuhiko Ishihara, Takao Hirano|Reviews of physiology, biochemistry and pharmacology|2003|673

Chronic inflammation and cancer.

Emily Shacter, Sigmund A Weitzman|PubMed|2002|637